A development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity its associated co-morbidities and other gastrointestinal disorders.


Updates from The Motley Fool

Latest updates on EnteroMedics from Fool.com.


Stock Performance

View Interactive ETRM Charts
Sponsored by

Key Data Points

Primary metrics and data points about EnteroMedics.
Current Price: $6.66
Prev Close: $7.15
Open: $7.50
Bid: $6.79
Ask: $6.84
Day's Range: $6.71 - $7.59
52wk Range: $1.75 - $88.55
Volume: 880,383
Avg Vol 7,096,824
Market Cap: $47M
P/E (ttm): -0.05
EPS (ttm): ($133.70)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about EnteroMedics.
CAPS Rating 1 out of 5
 
48 Outperform
16 Underperform
CAPS All Stars
 
12 Outperform
9 Underperform

How do you think EnteroMedics will perform against the market?



You pick for EnteroMedics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark B. Knudson, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for EnteroMedics.

A development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity its associated co-morbidities and other gastrointestinal disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT